> All News
> BASL News
> Hepatology News
> Nurse News
> Trainee News
> Transplant News
News Articles 141 - 150 of 160
The tenure of the current BASL President, Professor Graeme Alexander, will come to an end in September 2017. As such, BASL are now seeking expressions of interest for the position of BASL President.
The President is one of the three principal officers of the Association along with the Secretary and Treasurer. The President is Chairman of the Association and serves for two years. The President will Chair the annual Scientific Meeting and the meetings of the Governing Board.
Please send your nominations to the BASL Secretariat at Judith@execbs.com by the deadline of 09:00 Monday 3rd April 2017.
Candidates wishing to be considered for election will require one BASL member to propose them and a second BASL member to confirm their suitability for the role in writing.
If more than one candidate is nominated, the Secretariat will arrange for an election of all members. He/she will be elected by simple majority of those members voting. A member cannot be re-elected to the post of President.
A personal statement, containing no more than approx. 300 words, will be required from the candidate should an election need to take place.
The newly elected President will be announced at the next Business Meeting of the Association during the Annual Meeting in September 2017. A handover period will follow leading up to the end of the tenure of the current President.
If you require any further information please contact Judith@execbs.com .
Core and BSPGHAN are co-funding a scheme to provide financial support for the collection of pilot or proof-of-concept data that will enable a high-quality competitive application to be made subsequently to a research council or other large funder.
Applications are invited from established investigators planning research studies on any topic within paediatric gastroenterology, hepatology and nutrition. We aim to fund 2 projects with a maximum budget of £35,000 per project and particularly welcome applications in nutrition, obesity and the microbiome.
Further details and the application form can be found > here.
The University of Birmingham and NIHR Birmingham Liver BRU in conjunction with UK-PBC are conducting research into perspectives of patients, GPs and specialists around PBC care and potential future changes including an increased role for primary care.
We are looking for gastroenterologists and hepatologists in the West Midlands area to take part in qualitative interviews around the role of stratification.
Please see the advert to follow for further details; Download Physician advert.pdf
Or contact the study team led by Gideon Hirschfield for more details contact Dr Margaret Corrigan (Clinical research fellow, NIHR Liver Biomedical Research Unit) at email@example.com.
Responding to the Chancellor’s budget today, Professor Sir Ian Gilmore, Chair of the Alcohol Health Alliance, said:
“Whilst we would have liked to see the Chancellor increase duty on the cheapest alcohol today, we are encouraged to see that the government will be consulting on introducing a new duty band for high-strength ciders, which would mean these ciders are taxed at a higher rate.
“At the moment, it is possible to buy a three-litre bottle of 7.5% ABV cider, containing the equivalent amount of alcohol as 22 shots of vodka, for just £3.50. As a result of these low prices, these drinks are a favourite among children and vulnerable groups like the homeless.
“High-strength cider currently receives the lowest duty per unit of any alcohol product, and the government clearly recognises the need to address the anomalies in the tax system which mean that these ciders can be taxed at such low rates. Dealing with these anomalies in the tax system would target those most in need, and would move the tax system towards a more sensible scheme where the stronger alcohol is, the more highly it is taxed.
“By taxing these drinks more strongly, the government will also encourage producers to lower the alcohol content in the drinks.”
The AHA is a group of 50 organisations including the Royal College of Physicians, Royal College of GPs, British Medical Association, Alcohol Concern and the Institute of Alcohol Studies. The AHA works together to:
- Highlight the rising levels of alcohol-related health harm
- Propose evidence-based solutions to reduce this harm
- Influence decision makers to take positive action to address the damage caused by alcohol misuse
For further information, contact Matt Chorley, Policy and Communications Officer, Alcohol Health Alliance, at firstname.lastname@example.org or 0203 075 1726.
Report casts doubts on economic rationale for cuts to alcohol taxes.
A new report from the Institute of Alcohol Studies, Splitting the Bill: Alcohol's Impact on the UK Economy, argues that the economic benefits of the alcohol industry are overstated, undermining the economic case for cutting alcohol duty in next month's Budget.
The report draws on government and trade statistics, academic evidence and economic theory to challenge arguments that the health and social benefits of reducing alcohol consumption are likely to come at a cost to the economy, finding:
- Any reduction in employment and income resulting from lower spending on alcohol would be offset by spending on other goods
- Econometric analysis of US states suggests that a 10% decrease in alcohol consumption is associated with a 0.4% increase in per capita income growth
- Lower alcohol consumption could also reduce the economic costs of impaired workplace productivity, alcohol-related sickness, unemployment and premature death, which are estimated to cost the UK £8-11 billion a year.
The analysis comes at a timely moment, with health groups urging the Chancellor to raise alcohol duty in next month's Budget. Earlier this month, the Alcohol Health Alliance called for higher tax on high strength ciders and the reintroduction of the duty escalator, which ensured that alcohol taxes rose above inflation each year. Public Health England also recently identified raising duty as one of the most cost-effective ways to reduce alcohol-related harm.
The report's author, Aveek Bhattacharya, Policy Analyst at the Institute of Alcohol Studies said:
"Economic arguments are regularly used to resist policies that tackle excessive alcohol consumption, such as raising duty. Yet raising the price of alcohol is more likely to benefit the economy than harm it, by reducing the productivity costs associated with workers' harmful alcohol consumption."
"Cuts to alcohol duty impose a heavy toll on our health service and our public finances, with no clear corresponding benefit to the economy. The Government should reverse course, and undo the damage of four successive years of falling tax on alcohol duty."
Splitting the Bill: Alcohol's Impact on the UK Economy is available for download from the Institute of Alcohol Studies website > here.
The University of Birmingham and Queen Elizabeth Hospital Birmingham, with support from the RCP HIU, are developing national data standards for recording alcohol and tobacco use in electronic patient records. Recording alcohol and tobacco use in health records is essential for identifying patients at high risk of future harm and for providing effective interventions.
The views of patients, carers, healthcare professionals, researchers, and clinical information system suppliers are currently being sought through two online surveys (one on alcohol and one on smoking) to inform the development of the proposed data standards to ensure that they are appropriate, acceptable, and implementable across the NHS.
Your views are important:
• To complete the alcohol survey please click > here
• To complete the tobacco survey please click > here
Closing date: 5pm, 17 February 2017
On Friday 20th January, Ian Murray MP, the Member of Parliament for Edinburgh South, visited Edinburgh Royal Infirmary’s Gastroenterology Ward to discuss the effects of excessive alcohol consumption as part of the Alcohol Health Alliance’s (AHA) ‘Day of Action’.
This national initiative, instigated with the British Association for the Study of the Liver, sees the AHA working with doctors to raise awareness of alcohol-related liver disease.
The local MP met with Consultant Gastroenterologist Dr Alastair MacGilchrist to discuss his work and the impact that alcohol-related disease has on the lives of many of his constituents, and they met a number of Dr MacGilchrist’s patients to see first-hand the effect of cheap alcohol consumption on individuals.
Speaking at the visit, Ian Murray MP said:
“From my conversations with Dr MacGilchrist today it is clear that excessive alcohol consumption is having a devastating impact on the lives of too many people in my constituency and across Scotland. The ready availability of cheap alcohol is a huge part of this, and tackling the low cost of alcohol, as well as discouraging excessive consumption, should both be priorities for the Government. I welcome the work of the Alcohol Health Alliance on this, and I hope that their Day of Action is successful in raising awareness in communities across the country”.
This webinar is for anyone who wants to understand the challenges to reduce liver disease.
By joining the webinar participants will:
Explore the variations in liver disease risk factors and outcomes
Learn about PHEs programmes of action on liver disease
Look at time series data to identify where variation has improved, stayed the same or got worse
Explore the stories behind the data
Have an opportunity to ask a question to the national team
The webinar* will be held on Thursday 26 January 2016 - 2:00pm and 3:00pm.
Registration is FREE for this event and if you have already expressed an interest in attending this webinar, then we will have your details on our system. If you have not registered, please do so > Here:
If you have any questions about registration, please contact Kerry.email@example.com .
*Webinar details will be sent out prior to the session
The Gilead UK and Ireland Fellowship Programme 2017 will open soon for grant applications in the therapy area of viral hepatitis. The aim of the programme is to support local innovation and best practice in patient care.
The programme invites applications from healthcare or allied professionals that:
1. Innovative local integrated initiatives to evaluate effectiveness of non-hospital based HCV treatment service models
2. Novel HCV care pathways using partnership models demonstrating measurable improvements in patient engagement
Projects which fall outside of this scope but which will add clinical value or which investigate an area of unmet need within viral hepatitis can also be submitted and will be reviewed for their merit.
The Gilead UK and Ireland Fellowship Programme started in 2009, and since its inception has supported over 150 projects in the areas of HIV, Viral Hepatitis, Respiratory, Invasive Fungal Disease and Oncology.
You can apply for a viral hepatitis grant by clicking > here .